Pacira BioSciences, Inc. (PCRX) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
Pacira BioSciences, Inc. (PCRX) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
(PCRX) Goldman Sachs 47th Annual Global Healthcare Conference 2026 June 8, 2026 1:20 PM EDT Matthew Dellatorre - Goldman Sachs Group, Inc., Research Division Matthew DellatorreGoldman Sachs Group, Inc., Research Division Great.
Good afternoon, everyone, and thank you for joining us.
I'm a biopharma analyst here at Goldman Sachs.
And we're very pleased to continue the next session this afternoon with Pacira Biosciences, where I'm joined by the company's CEO, Frank Lee.
Matthew DellatorreGoldman Sachs Group, Inc., Research Division Frank, maybe to start just to get everyone up to speed before we dive into some of the specific programs, maybe for those less familiar with Pacira, give us a brief overview of the company.
And then maybe frame for us where you all stand today, what your key priorities are and then how you're thinking about the outlook and strategy for the company as we head into second half and beyond.
Well, Pacira, as many of you know, is a leader in non-opioid pain management therapies.
And what does that mean? That means that we have 3 products in our portfolio plus a pipeline that's growing that we should talk about.
And as we think about sort of the company's history then and now, I mean, we had a pretty substantial reset of the organization.
I'm with the organization just over 2 years, joined in 2024.
And in '25, we rolled out the 5x30 strategy for value creation..
| Product | Price | Change |
|---|---|---|
| Brent Crude | $102.14/bbl | +0.34% |
| WTI Crude | $96.90/bbl | +0.21% |
| EN590 Diesel | $846/MT | +0.18% |
| Jet Fuel A-1 | $1090/MT | +0.55% |
| Mazut M100 | $450/MT | -0.15% |
| Bitumen 60/70 | $470/MT | +0.08% |
| Sulphur Gran 99.5% | $470/MT | -0.44% |
| Urea 46% Gran | $650/MT | +1.12% |
| NPK 16-16-16 | $460/MT | -0.28% |
| Nat Gas TTF | $15.42/MMBtu | +0.92% |
Comments
Post a Comment